You are here: Industry Insights > Merck

News List

Merck, Premier to codevelop new interventions for C. diff infection biospectrumasia
June 04, 2018
Since 2016, Merck and Premier have colaborated to co-develop and test solutions that help promote wellness and prevention for specific groups of at-risk patients
With global supplies running short, stepped-up Chinese demand paralyzes Gardasil market in Hong Kong, S.A.R., China fiercepharma
May 29, 2018
Before Merck & Co.'s Gardasil 9 won conditional approval on the mainland just last month...
Merck rains on Roche's parade with double Keytruda win in squamous lung cancer fiercepharma
May 28, 2018
Merck & Co. already controls a big part of the first-line non-small cell lung cancer market, and it likely just secured most of the rest of it.
In a win for Merck—and, just maybe, for pharma—Solicitor General urges SCOTUS to hear Fosamax case fiercepharma
May 28, 2018
Merck & Co.'s effort to take its Fosamax appeal to the Supreme Court just got a boost, and the entire pharma industry should take note.
Oncolytics, Merck, Northwestern Conduct Phase II Combo Trial contractpharma
May 22, 2018
Oncolytics Biotech Inc., currently developing REOLYSIN (pelareorep), an intravenously delivered immuno-oncolytic virus turning cold tumors hot,
Merck to Use Genome Editing in Study of Gut Bacteria to Benefit Malnourished Children americanpharmaceuticalreview
May 18, 2018
The two-year collaboration will employ Merck's CRISPR genome-editing technology in research studies by Dr. Jeffrey Gordon of Washington University School of Medicine.
Merck's experimental Ebola shot gets set to fight deadly new outbreak in Congo fiercevaccines
May 17, 2018
As the death toll mounts in a new Ebola outbreak in the Democratic Republic of Congo, health officials are preparing to deploy Merck & Co.'s experimental vaccine against the virus.
Merck Highlights Anemia’s Higher Risk for Pregnancy, Continues Awareness Advocacy pharmafocusasia
May 14, 2018
Global healthcare and pharmaceutical company Merck continues to spread awareness about anemia in Asia.
Boosted by China launch, Merck's Gardasil turns in a big first-quarter performance fiercepharma
May 09, 2018
Even as Merck's Gardasil sales suffer in the U.S. from the CDC's decision to implement a two-dose regimen, the HPV vaccine franchise posted strong growth in the first quarter as a China launch begins to pay off.
Why did Merck issue an unusual press release? It knows investors are hyperfocused on I-O data fiercepharma
May 08, 2018
Investor “conspiracy theories” are real in immuno-oncology, something Merck & Co. knows all too well. So well, in fact, that the company recently changed up its communications game to address investor fears directly.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 51 52 Next page